According to the article at the American Enterprise Insitute: Because there is usually a large price differential between brand and generic drugs, a high generic substitution rate ensures cost-effectiveness in the Medicaid drug program without engaging in policies that affect clinical decisions.
Read the white paper here:
http://bit.ly/a0Iqwm
![](http://4.bp.blogspot.com/_aUNWs0r0e_E/TB-W6xfTXII/AAAAAAAABI8/vmNyNRUrvNs/s200/P1558_CoverArt.jpg)
No comments:
Post a Comment